Post-hoc tests detected significant improvement of stroke-induced neurological deficits in rats given G-CSF + tPA 7 days after stroke (p < 0.01), compared with rats subjected to tPA treatment only (Figure 2B). The gene discussed is CSF3; the disease is stroke disorder.